Recent session action on shares of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) puts the stock on today’s active list. Since the open, shares have moved -5.88% after recently hitting the $4.89 mark.
Digging a bit further, company shares have been noted -24.12% off the 52 week high and 103.94% away from the 52 week low. Looking at a shorter time period, shares have been seen -24.12% away from the 50 day high and 45.02% off the 50 day low price.Covering sell-side analysts have recently weighed in on shares of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP). At the time of writing, the First Call consensus price target for the company is $10.00. The current consensus recommendation provided by covering analysts is 2.00. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is 65.08%. For the quarter, shares have been noted at 14.29%. Share performance for the month is currently at 42.47%. Tightening the gaze, stock performance for the last 5 trading days is 20.93%.